NEW YORK, July 22, 2021 /PRNewswire/ -- Technavio's latest report on the companion animal specialty drugs market projects a growth of USD 2.80 billion, registering a CAGR of 5.20% during 2021-2025. According to the report, the Pharmaceuticals sector will have a POSITIVE impact owing to the continued spread of the COVID-19 pandemic. Besides, the report provides a detailed analysis of the pre-and post-impact of COVID-19 on businesses.
Download a Sample Report Covering COVID-19 Impact
The companion animal specialty drugs market share growth by the vaccines segment has been significant.
The US is a key market for companion animal specialty drugs in North America. 39% of the market's growth will originate from North America during the forecast period. North America has been recording significant growth rate and is expected to offer several growth opportunities to market vendors during the forecast period. The rising awareness about disease prevention and pet insurance will facilitate the companion animal specialty drugs market growth in North America over the forecast period.
Companion Animal Speciality Drugs Market: Major Growth Drivers
The following factors are expected to drive the growth of the market during the forecast period:
Also, the ongoing trend of enhanced product offerings is expected to have a positive impact on the growth of the companion animal specialty drugs market during 2021-2025.
Gain more insights into the global trends impacting the future of companion animal specialty drugs market.
Request a Free Sample Report Now!
Companion Animal Speciality Drugs Market: Key Vendor Offerings
Bayer AG
Bayer AG operates its business under segments- Pharmaceuticals, Crop science, and Consumer health. The company offers Veterinary Medicines.
Boehringer Ingelheim International GmbH
Boehringer Ingelheim International GmbH operates its business under segments- Human Pharmaceuticals, Animal Health, Biopharmaceuticals, and Other. The company offers products for animal health.
Ceva Sante Animale
Ceva Sante Animale operates its business under segments- Companion animals, Cattle, Poultry, Small Ruminants, and Swine. The company offers companion animal specialty drugs.
Reasons to Buy Companion Animal Specialty Drugs Market Report:
This report can be personalized according to your business needs.
Related Reports on Information Technology Include:
Animal Health Market in North America: Technavio's market research analyst predicts the global animal health market to grow at a CAGR of 4% during the forecast period.
Download Exclusive Free Sample Report of the Latest Version
Global Animal Antimicrobials and Antibiotics Market: Technavio's analysts forecast the global animal antimicrobials and antibiotics market to grow at a CAGR of 5.25% over the forecast period.
Download Exclusive Free Sample Report of the Latest Version
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
Report: https://www.technavio.com/talk-to-us?report=IRTNTR44185
SOURCE Technavio
These press releases may also interest you
|